Article abstract-Using a population-based regional cohort of 479 children with epilepsy, we studied the effect of the number of pretreatment afebrile seizures on seizure control and remission. The number of pretreatment seizures varied from 1 to 20. For the first 10 pretreatment seizures, there was no significant difference or trend in (1) the proportion of children who were seizure free long enough to attempt stopping medication (mean, 70%), (2) the number of breakthrough seizures before control was achieved, or (3) the proportion of children who were seizure free after stopping medication for the first time (mean, 70%). More patients with more than 10 pretreatment seizures had complex partial seizures (59%) than those with 10 or fewer seizures 116%) (p < 0.00001). We conclude that there does not appear to be any penalty for seizure control or early remission of epilepsy if medication is delayed for up to 10 pretreatment seizures.
The diagnosis of epilepsy is conventionally made after two unprovoked seizures. Daily antiepileptic medication is often prescribed at this point, with the expectation that further seizures will be avoided. It is not clear whether prevention of further seizures alters the tendency of many children to outgrow their epilepsy. Experimental kindling of epilepsy in animals raises the point that each seizure "greases the track" for the next seizure, i.e., seizures beget seizures.l The relevance of kindling of experimental seizures in animals to epilepsy in children is uncertain. In kindling models, subclinical electrical stimulation eventually leads to spontaneous seizures. More than 10 stimulation events are required before seizures occur, and the stimulation must occur very regularly and at short intervals. There does not appear to be a clear human equivalent to subclinical stimulation.' Nonetheless, the existence of experimental kindling may make clinicians anxious t o give children who have recurrent seizures antiepileptic medication as soon as possible.
If the course of epilepsy in children follows a similar pattern to that of experimental kindling, there should be a relationship between the number of seizures before treatment and both the ease of seizure control and the rate of eventual remission of epilepsy. If seizures do not beget seizures, it may be reasonable to withhold medication, for selected children, until several seizures have occurred. Some children with epilepsy might avoid drug treatment completely.
We address the question, Does the number of seizures before antiepileptic drug (AED) treatment influence the ease of seizure control or the chance that medication can be successfuIly withdrawn?
Methods. The IWK Children's Hospital in Halifax is the only tertiary pediatric center in the province of Nova Scotia (population of approximately 850,000). All pediatric neurologists in the province are located at this hospital, and we have an extensive pediatric neurology traveling clinic system throughout the province. All EEGs for the province are interpreted by the pediatric neurologists at IWK Children's Hospital.
Our previous studies suggest that virtually all children presenting to a physician with a first seizure need to have an EEG.2 Therefore, we are confident that all those presenting with a second seizure have had at least one EEG; hence, EEG records were a comprehensive source for identifylng pediatric seizure patients in the province. The detailed methods of case ascertainment have been previously p~blished.~ In brief, all EEG reports for children in Nova Scotia in the study period 1977-1985 were reviewed. For each possible patient, information was gathered from the hospital's or the neurologist's charts or by direct contact with the family doctor. When information was incomplete, parent(s) or the patient was contacted directly both for .~ -initial and followup information from 1987 to 1990. Nearly all patients (97%) had been seen by our pediatric neurology service at some point in the evolution of their disorder.
The inclusion and exclusion criteria are listed in table 1. Epilepsy was defined as two or more unprovoked seizures. Children treated with daily AED therapy after their first seizure were only included if they eventually had a second seizure. We emphasize that children were excluded if they had myoclonus; absence (typical or atypical), akinetic or atonic seizures; or infantile spasms.
In this study we only considered the patient's initial medication period. In all patients, daily AED treatment was started after diagnosis. Some patients continued on medication until their final followup. Others attempted to discontinue medication after a seizure-free period. The decision to discontinue medication was made by the family and attending physician based on clinical factors. Many children withdrew from AED treatment successfully, but others relapsed and restarted daily medication. Some attempted to discontinue medication a second or third time; however, only their first attempt is considered in this report.
The number of pretreatment seizures was coded as 1 to 20, with greater numbers coded as >20. Because few patients had l l to 21 pretreatment seizures, we grouped together all those with more than 10 pretreatment seizures. Children with an unknown number of pretreatment seizures were excluded unless that number was clearly more than 10. If a child had a first seizure that was unprovoked, fully recovered consciousness, and then had a recurrence on the same day, the second seizure was defined as the first recurrence. ' If a child became seizure free for a period that the child's physician and family agreed was sufficient, medication was tapered and then discontinued. The child was then defined as seizure free if he or she experienced no more seizures off medication until the end of followup.
Breakthrough seizures were defined as seizures occurring after medication was prescribed but before medication was withdrawn for those patients who were seizure free for a sufficient period. Information about compliance at the time of breakthrough seizures was not available. Our pre-42 NEUROLOGY 46 January 1996 
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The neurologic examination was normal in 373 patients (78%) and revealed a major abnormality in 53 (11%). Intelligence was judged to be normal in 326 patients (68%), whereas 57 (12%) had a mental handicap and another 77 (16%) had a learning disorder.
The first seizure type was generalized tonic-clonic in 120 patients (25%), simple partial in 19 (4%), complex partial in 124 (26%), partial with secondary generalization in 177 (26%), rolandic in 29 (6%), and "other" in 10 (2%). The initial medication prescribed was phenobarbital in 211 patients (44%), carbamazepine in 177 (37%), phenytoin in 53 (ll%), valproic acid in 10 (2%), and "other" in 28 (6%).
Seizure-free period during AED treatment. Overall, 331 patients (70%) became seizure free long enough to attempt discontinuation of medication. The mean seizure-free period while being treated with AED was 31 2 17 (SD) months. If the number of pretreatment seizures was 10 or fewer, the specific number did not influence the proportion of patients who became seizure free long enough to attempt discontinuation of medication (table 2). Only 55 of the 99 patients (56%) with more than 10 pretreatment seizures were seizure free for a sufficient time to attempt discontinuation of medication, compared with 276 of 380 patients (73%) with 10 or fewer seizures ( p = 0.001, chisquare test).
Discontinuation of AED treatment. When patients discontinued AED treatment, overall, 232 of the 331 patients (70%) remained seizure free off AED therapy. For the 232 seizure-free patients, the mean followup after AED discontinuation was 39 ? 19 (SD) months. For each pretreatment seizure number, the number of patients successfully stopping AED treatment was the same (see table 2 ). The only exception was the group treated after a single seizure. Of this group, 27 of 48 patients (57%) were seizure free after Data about breakthrough seizures were not available for those patients with more than 10 seizures before treatment.
* These children were eventually taken off medication and then had at least one recurrence.
AED discontinuation, compared with 205 of 284 patients (72%) with more than one pretreatment seizure ( p = 0.04, chi-square test). Breakthrough seizures while receiving AED treatment. Once AED treatment was started, the number of breakthrough seizures before complete control did not differ from the number of pretreatment seizures, again with the exception of those patients with only one pretreatment seizure (table 3) . This analysis applies only to the 276 patients with 10 or fewer pretreatment seizures plus sufficient seizure control to attempt discontinuation of medication. Unfortunately, because of our coding system, data for this issue were not available for those patients with more than 10 pretreatment seizures. Of those patients with only one pretreatment seizure, 7 of 47 (15%) had no more seizures when medication was started, compared with 119 of 229 patients (52%) with more than one pretreatment seizure ( p < 0.0001, chi-square test).
Children with one pretreatment seizure. The mean time from first to second seizure for patients treated after only one pretreatment seizure was significantly longer than for those treated after more seizures (mean, 14.9 versus 4.4 months; p < 0.00001, Mann-Whitney test).
Children with more than 10 pretreatment seizures.
Those patients with more than 10 pretreatment seizures were more likely to have complex partial seizures than those with fewer pretreatment seizures (60 of 99 versus 62 of 380; p < 0.00001, chi-square test). They also had a younger average age of onset of epilepsy (mean, 71.6 versus 84.1 months; p = 0.05, Mann-Whitney test). They were not more likely to have neurologic, intellectual, or behavioral disabilities (see reference 3 for definitions).
Discussion. Based on our experience, the number of seizures before a child is started on AED treatment has little influence on the ease of seizure control, the likelihood of becoming seizure free long enough to consider discontinuing medication, or the chance of seizure recurrence after stopping treatment for the first time. Children with more than 10 pretreatment seizures appear to have a reduced chance of completely controlling their seizures with daily AED treatment, but if controlled, the chance of successfully stopping medication is unchanged. We did not include children with initial absence, akinetic, or atonic seizure; myoclonus; or infantile spasms in this study. These disorders virtually always present with seizures too numerous to count.
Our study was population based and the decision of when to start medication was made by the family and physician. We doubt that treatment was deliberately withheld in many of these children until there were multiple seizures. Between 1977 and 1985, our usual practice was to start daily medication after one or two seizures. Children with more than two pretreatment seizures most likely did not present to a physician until multiple seizures had occurred.
AEDs were nearly always discontinued if a child was seizure free for 2 to 4 years. Overall, only 18 of the 479 children were seizure free, having made no attempt to stop medication, for more than 4 years. Because we found no trend in the difficulty of seizure control or remission of epilepsy with increasing pretreatment seizure (<lo), a randomized trial would probably not yield different results. In a randomized Italian study of 397 adults and children, the investigators found no difference in long-term remission when medication was started after the first or second s e i z~r e .~,~ Children treated after having more than 10 seizures had a different clinical profile than those treated earlier. They were younger a t onset and more likely to have complex partial seizures, suggesting that these seizures are not easily recognized by parents. However, once these children became seizure free with medication, there was no reluctance to attempt medication withdrawal. Only 5% of children with more than 10 pretreatment seizures were seizure free, having made no attempt to stop medication, for more than 4 years compared with 3.4% of those with fewer pretreatment seizures. The rate of successful medication discontinuation was the same with all pretreatment seizure numbers.
We cannot conclude that earlier treatment would have made a difference in seizure control for those with more than 10 pretreatment seizures. Perhaps younger children with many seizures before treatment have a form of epilepsy that is unlikely to remit. In a previous study using multivariate analysis, we noted that more than 20 seizures before treatment was predictive of a low rate of long-term remission, independent of seizure type.3 Therefore, the effect of a very large number of pretreatment seizures is only partially explained by the overrepresentation of complex partial seizures in this group.
Only one-half of children with a first seizure have a recurrence.2 Based on our data, it appears that children treated after a single seizure have a more difficult clinical course than those treated after multiple seizures; however, this impression is undoubtedly the result of our inclusion criteria. To be included, children had to have had two or more seizures. Those treated after a first seizure were included if they had an additional seizure on medica-tion or further seizures when medication was discontinued. Those who had no recurrences after their first seizure were excluded from the study.
In adults, the impact of multiple seizures before treatment is controversial. Elwes et a1 suggested that "a high frequency of tonic-clonic seizures before treatment" was associated with unsatisfactory seizure contr01.~ On the other hand, Sander concluded that there was little evidence in untreated populations to implicate an adverse effect on remission from multiple seizures. lo Studies, specifically in children, have not directly focused on the issues raised in this paper." In two population-based studies of childhood epilepsy, the investigators noted that frequent "early" seizures are predictive of a poor progn o s i~. '~J~ In both studies, the early seizures occurred after medication was started.
In 1881, Gowers wrote of epilepsy: "The tendency is for self perpetuation: each attack facilitates the occurrence of another."'* We disagree, at least for children who have had 10 or fewer seizures before treatment. We suspect that the current "standard of practice" is to prescribe daily medication for children who have had two seizures. Our paper offers reassurance to families who choose to delay medication until a child with epilepsy has had a substantial number of ~eizures.'~ There does not appear to be any penalty for seizure control or remission if medication treatment is delayed for up to 10 seizures. If early medication does not have an effect on the longterm prognosis of childhood epilepsy, then, initially, the only rationale for treatment would be avoidance of injury or avoidance of adverse social consequences. We are unaware of studies addressing the frequency or severity of injury based on pretreatment seizure number. The social outcome of our patients was not related to the number of pretreatment seizures. 16 The rationale for medication treatment for children who have had 10 or fewer seizures requires further study.
